A pair courts decisions have a big impact on remedies available for biotechnology patent infringement. Defendants in biotech patent lawsuits seem to be better off than previously thought. The result could mean revaluing Canadian patent portfolios based on enforceability issues, and revising business and intellectual property practices accordingly.
Read the details in my article in The Lawyer’s Weekly, “New Directions for Biotech Patent Remedies.”
|look inside >|